Nature's Sunshine Products, Inc.

NATR Consumer Defensive Packaged Foods

Nature's Sunshine Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $480.1 million, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.95%, EPS fell 31.0% and free cash flow fell 164.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

12.64 0.00 0.00%
Market cap
$222.4M
P/E
12.4×
Fwd P/E
16.4×
Dividend yield
—
F-score
8/9
Altman Z
5.37
Beneish M
−2.83
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
19.98 36.65 22.18 0.00 12.76 13.59 25.51 0.00 0.00 121.25
Piotroski F-Score
8 6 8 5 7 6 6 6 5 5
P/S ratio
0.81 0.60 0.76 0.39 0.83 0.76 0.48 0.43 0.64 0.80
Altman Z-Score
5.37 5.02 4.93 3.89 5.02 4.28 3.53 3.51 3.80 4.39
P/FCF ratio
13.47 19.05 11.00 0.00 13.12 8.92 50.09 7.07 39.51 0.00
Altman Z″-Score (non-manufacturers)
5.82 6.04 5.35 5.23 5.31 4.93 3.89 3.26 3.32 3.43
Beneish M-Score
(2.83) (2.70) (3.29) (1.93) (2.40) (2.74) (2.33) (3.19) (3.16) (2.50)
P/Operating CF
39.26 22.40 35.24 46.10 25.64 27.02 56.87 20.43 88.04 (165.68)
P/B ratio
2.41 1.70 2.12 1.12 2.28 1.86 1.33 1.29 1.83 2.06
Price to Tangible BV
2.41 1.70 2.12 1.12 2.28 1.86 1.34 1.30 1.84 2.07
EV/Sales
0.62 0.42 0.60 0.28 0.64 0.53 0.40 0.30 0.56 0.73
EV/EBITDA
7.72 5.58 8.78 4.39 6.19 6.32 5.45 7.10 18.95 16.77
EV/Operating CF
8.44 7.57 6.51 168.64 8.19 5.41 17.03 4.93 18.04 72.89
EV/FCF
10.33 13.37 8.73 (17.31) 10.13 6.22 42.26 4.88 34.25 (32.72)
Quick Ratio
1.31 1.43 1.19 1.13 1.24 1.43 1.05 0.88 0.97 0.66
Current Ratio
2.28 2.44 2.16 2.28 2.15 2.21 1.95 1.60 1.91 1.50
Net Debt/EBITDA
(2.43) (2.47) (2.69) (2.16) (1.83) (2.74) (1.01) (3.24) (2.92) (1.63)
Debt/Assets
0.00% 0.00% 0.00% 0.51% 0.93% 1.49% 12.52% 0.79% 7.01% 4.83%
Debt/Equity
0.00 0.00 0.00 0.01 0.02 0.02 0.21 0.01 0.11 0.07
Asset Turnover
1.91 1.85 1.86 1.73 1.75 1.67 1.78 1.88 1.71 1.68
Operating CF/Net income
1.81 3.29 2.73 (1.82) 1.20 1.77 1.26 (25.57) (0.81) 1.60
Capex/Depreciation
(0.47) (0.77) (0.89) (0.69) (0.59) (0.46) (0.48) 0.02 (0.58) (2.40)
Interest Coverage
252.48 137.64 271.72 65.29 138.68 210.61 375.00 13.83 4.80 627.44
ROE
12.10% 4.80% 9.83% (0.25%) 18.11% 14.89% 5.41% (0.71%) (10.27%) 1.59%
ROA
7.78% 3.14% 6.29% (0.16%) 11.35% 9.23% 3.33% (0.44%) (6.46%) 1.05%
ROIC
22.86% 16.46% 15.19% 11.52% 27.91% 19.49% 9.83% 4.68% 0.96% 5.80%
Return on Tangible Assets
14.65% 5.72% 11.25% (0.30%) 20.78% 15.38% 5.92% (0.82%) (10.97%) 2.04%
Average Days of Receivables
6.54 7.61 7.23 12.20 7.29 6.99 7.38 7.76 9.48 8.28
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
67.27% 67.04% 67.90% 67.19% 66.19% 68.13% 69.61% 72.30% 72.98% 70.40%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
1.20% 1.05% 1.10% 0.69% 0.84% 0.98% 0.59% 0.59% 0.65% 0.94%
Graham Net Nets
0.20 0.30 0.22 0.41 0.18 0.21 0.17 0.22 0.12 0.08
Graham Number
14.77 8.82 12.27 0.00 16.28 14.11 7.26 0.00 0.00 4.37
Earnings Yield
5.00% 2.73% 4.51% (0.23%) 7.84% 7.36% 3.92% (0.49%) (5.95%) 0.82%
Free Cash Flow Yield
7.42% 5.25% 9.09% (4.20%) 7.62% 11.21% 2.00% 14.14% 2.53% (2.79%)
Revenue per Share
26.67 24.41 23.36 21.83 22.36 19.72 18.75 19.08 18.11 18.21
Operating CF per Share
1.96 1.36 2.16 0.04 1.74 1.93 0.44 1.14 0.56 0.18
Capex per Share
(0.36) (0.59) (0.55) (0.39) (0.33) (0.25) (0.26) 0.01 (0.26) (0.62)
Free Cash Flow per Share
1.60 0.77 1.61 (0.36) 1.41 1.68 0.18 1.15 0.29 (0.43)
Cash per Share
5.21 4.55 4.32 3.11 4.34 4.71 2.78 2.65 2.27 1.82
Shareholders Equity per Share
8.97 8.65 8.37 7.61 8.13 8.05 6.70 6.30 6.34 7.07
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
8.97 8.65 8.37 7.61 8.13 8.05 6.70 6.30 6.34 7.07
Free Cash Flow
28.84 14.33 30.75 (6.92) 28.00 32.75 3.44 22.04 5.54 (8.12)
Working Capital
100.31 94.89 89.06 83.93 88.00 84.41 54.76 40.14 48.85 31.47
Capital Expenditures
(6.48) (10.97) (10.48) (7.63) (6.61) (4.90) (5.10) 0.21 (4.98) (11.54)
Net Current Asset Value
79.25 80.72 75.58 66.78 67.20 61.80 29.07 34.38 27.05 21.33
EV/EBIT
12.04 9.53 14.31 7.36 8.18 9.48 9.02 20.11 136.90 24.81
Capex to Sales
0.01 0.02 0.02 0.02 0.01 0.01 0.01 0.00 0.01 0.03
Price to Operating Income
15.70 13.58 18.04 10.14 10.60 13.60 10.70 29.13 157.92 27.15
Other line items
Depreciation/Fixed assets
0.42 0.36 0.26 0.24 0.22 0.20 0.18 0.15 0.12 0.07
Cash ROIC
11.29% 5.83% 12.71% (3.32%) 11.20% 12.94% 1.64% 12.76% 3.14% (4.60%)
Accounts Receivable Turnover
53.12 49.65 38.84 36.72 54.67 52.43 48.07 43.85 41.14 44.20
Accounts Payable Turnover
15.64 15.42 17.42 15.22 14.27 18.60 19.52 20.29 19.13 15.62
Inventory Turnover
2.07 2.05 1.84 1.90 2.13 2.15 2.12 2.22 1.99 2.11
Average Days of Payables
22.11 25.08 23.25 18.97 30.67 23.38 17.12 19.91 16.90 21.29
Days of Inventory on Hand
188.29 167.31 196.60 203.04 192.36 171.85 181.32 160.39 176.60 191.04
Average Receivables
9.04 9.15 11.47 11.49 8.12 7.35 7.54 8.32 8.31 7.72
Average Payables
8.47 8.41 7.13 8.03 8.09 5.45 4.81 4.72 4.76 5.82
Average Inventory
63.88 63.17 67.42 64.40 54.27 47.17 44.36 43.05 45.82 43.05
Average Assets
251.00 245.31 239.78 244.33 254.19 231.28 203.04 194.11 200.38 203.05
Average Common Equity
161.27 160.27 153.29 154.23 159.32 143.34 125.00 120.15 126.07 134.33

Fold the line items

Columns are period end dates